Active participation in international conferences and symposiums (20)
  1. 6. Ando, K., De Decker, R., Vergara Panos, C., Yilmaz, Z., Mansour, S., Suain, V., Slegers, K., De Fisenne, M.-A., Houben, S., Potier, M.-C., Duyckaerts, C., Watanabe, T., Buée, L., Leroy, K., & Brion, J. P. (2021). Picalm reduction exacerbates tau pathology in a murine tauopathy model. (p. 77, Poster 04) Abstract session presented at  New Horizons in Alzheimer’s Disease(October 27-28, 2021: Leuven, Belgium).
  2. 7. Kosa, A.-C., Ando, K., Lasri, H., Yilmaz, Z., Doeraene, E., López Gutiérrez, L., De Decker, R., Mansour, S., Suain, V., & Brion, J. P. (2021). Deletion of murine APP accelerates cognitive deficits in a murine model of amyloid and tau pathologies. (p. 129) Abstract session presented at New Horizons in Alzheimer’s Disease(October 27-28, 2021: Leuven, Belgium.).
  3. 8. Ando, K., Ndjim, M., Turbant, S., Fontaine, G., Pregoni, G., Dauphinot, L., Suain, V., Mansour, S., Authelet, M., De Decker, R., Delatour, B., Brain Bank NeuroCEB Neuropathology Network,, Duyckaerts, C., Leroy, K., Potier, M.-C., & Brion, J. P. (2021). The lipid phosphatase Synaptojanin 1 undergoes a significant alteration in expression and solubility and is associated with brain lesions in Alzheimer’s disease. (p. 60) Abstract session presented at Poster presentation to the Third Eurotau meeting(October 25-26, 2021: Lille, France).
  4. 9. De Fisenne, M.-A., Houben, S., Ando, K., Vanden Dries, V., Poncelet, L., Yilmaz, Z., Mansour, S., De Decker, R., Brion, J. P., & Leroy, K. (2021). Intravenous injection of PHF-tau proteins from Alzheimer brain exacerbates neuroinflammation, amyloid beta and tau pathologies in APP/PS1 transgenic mice. (p. 98) Abstract session presented at New Horizons in Alzheimer’s Disease(October 27-28, 2021: Leuven, Belgium).
  5. 10. Doeraene, E., Erneux, C., Yilmaz, Z., Mansour, S., Suain, V., Turbant, S., Duyckaerts, C., Brain Bank NeuroCEB Neuropathology Network,, Schurmans, S., Brion, J. P., Leroy, K., & Ando, K. (2021). Protein level and solubility of the PI 5-phosphatase SHIP2 is altered in correlation with Amyloid pathology in Alzheimer’s brains. (p. 75) Abstract session presented at Poster presentation to the Third Eurotau meeting(October 25-26: Lille, France).
  6. 11. De Fisenne, M.-A., Houben, S., Ando, K., Vanden Dries, V., Poncelet, L., Yilmaz, Z., Mansour, S., De Decker, R., Brion, J. P., & Leroy, K. (2021). Intravenous injection of PHF-tau proteins from Alzheimer brain exacerbates neuroinflammation, amyloid beta and tau pathologies in APP/PS1 transgenic mice. (p. 72) Abstract session presented at Poster presentation to the Third Eurotau meeting(October 25-26: Lille, France).
  7. 12. Ando, K., Pregoni, G., Verheijen, J., Vergara Panos, C., De Decker, R., Mansour, S., Yilmaz, Z., Suain, V., Dauphinot, L., Fontaine, G., Leroy, K., Duyckaerts, C., Sleegers, K., Potier, M.-C., & Brion, J. P. (2019). Picalm susceptibility RS3851179 locus for late onset Alzheimer's disease affects the levels of its mRNA and protein expression in human. Abstract session presented at 14th conference of Alzheimer and Parkinson's diseases (ADPD)(26-31 march 2019: Lisbon, Portugal)
  8. 13. Poncelet, L., Ando, K., Vergara Panos, C., Gilissen, E., Yilmaz, Z., Mansour, S., Brion, J. P., & Leroy, K. (2019). Aged cats: a naturally occuring model of tauopathy. Abstract session presented at 14th conference of Alzheimer and Parkinson's diseases (ADPD)(26-31 march 2019: Lisbon, Portugal)
  9. 14. Vergara Panos, C., Houben, S., Suain, V., Yilmaz, Z., De Decker, R., Vanden Dries, V., Mansour, S., Boom, A., Ando, K., Brion, J. P., & Leroy, K. (2019). Amyloid pathology enhances seeding and propagation of fibrillar endogenous non-mutant tau in vivo through p25/CDK5 activation. Paper session presented at 14th conference of Alzheimer and Parkinson's diseases (ADPD) (26-31 march 2019: Lisbon, Portugal).
  10. 15. Brion, J. P., Vergara Panos, C., Houben, S., Suain, V., Yilmaz, Z., De Decker, R., Boom, A., Mansour, S., Buée, L., Vanden Dries, V., Ando, K., & Leroy, K. (2019). Tau pathology propagation in mice models induced by native human Alzheimer PHF. Abstracts of the Conference Abstract session presented at Oral presentation to the "14th conference of Alzheimer and Parkinson's diseases (ADPD)"(26-31 march 2019: Lisbon, Portugal)
  11. 16. Vergara Panos, C., Houben, S., Suain, V., Yilmaz, Z., De Decker, R., Mansour, S., Boom, A., Leroy, K., Ando, K., & Brion, J. P. (2018). Amyloid pathology enhances seeding and propagation of fibrillar endogenous non-mutant tau in vivo. Frontiers in Neuroscience Abstract session presented at Belgian Brain Conference 2018(2018-10-19: Liège)
  12. 17. Vergara Panos, C., Houben, S., Suain, V., Yilmaz, Z., De Decker, R., Mansour, S., Boom, A., Leroy, K., Ando, K., & Brion, J. P. (2018). Amyloid pathology enhances seeding and propagation of fibrillar endogenous non-mutant tau in vivo. Abstract session presented at Eurotau(27 April 2018: Lille)
    13. << Previous 1 2 3 Next >>